Crystals were obtained by equilibrating a reservoir solution containing 13% polyethylene glycol 8000, 1 M sodium chloride and 0.1 M Tris-hydroxyethyl aminomethane/HCl buffer at pH 8.0 against 8 µl of a 1:1 mixture of 30 mg/ml of MoFe protein and the reservoir solution under strictly anaerobic conditions.
Crystals were reduced by addition of 10 mM sodium dithionite to the cryo buffers.
2-methyl-2,4-pentanediol (MPD)
Purified iron protein was typically 20 to 30 mg ml-'
crystals were grown by a microcapillary batch method (23) by using a 2:1 ratio of precipitant (30 percent PEG 4000, 0.20 M Na2MoO4, 100 mM tris, pH 8.3) to protein at a concentration of 20 to 30 mg/ml in 50 mM tins, pH 8.0, 2 mM Na2S204, and 0.45 M NaCl.
Crystals were grown by the capillary microbatch method (16) with 20 íL of precipitant solution containing 26-29% PEG 4000, 700-900 mM NaCl, and 100 mM Tris (pH 8.0) and 10 íL of protein solution containing 30 mg/mL all-ferrous Av2 in 20% glycerol, 450 mM NaCl, and 50 mM Tris (pH 8.0).
Ti(III) citrate was removed from the Fe protein on a Sephadex G-25 column, and the protein was concentrated in a Centricon-30 apparatus in an anaerobic centrifuge to a final concentration of 30 mg/mL in 20% glycerol, 450 mM NaCl, and 50 mM Tris (pH 8.0).
23% polyethylene glycol (MW 3350 g/mol, Hampton Research), 0.2 M lithium citrate (Aldrich), and 5 mM sodium dithionite (J.T. Baker).
Crude extracts were prepared by the osmotic shock method (22) in a degassed buffer that contained 25 mM Tris-HCl (pH 7.9) and 1 mM sodium dithionite. For crude extract preparation, the buffer also contained 0.2 mM PMSF to inhibit protease activity. Prior to purification, the extracts were brought to 500 mM in NaCl by the addition of degassed, granular NaCl.
Cell extracts were loaded onto a Zn(II)-charged IMAC column (90 mL of resin in a 2.5 cm x 30 cm column) using a peristaltic pump. After loading the extract, the column as washed with three column volumes of Buffer A (25 mM Tris-HCl, pH 7.9, 500 mM NaCl, 1 mM sodium dithionite) containing 40 mM imidazole-HCl. The protein that remained bound to the column was then eluted using Buffer A containing 250 mM imidazole-HCl. The eluted protein was collected and diluted 8-fold in a degassed buffer (25 mM Tris-HCl, pH 8.0) containing 1 mM sodium dithionite.
The diluted protein was then loaded onto a DEAE-Sepharose column (30 mL of resin in a 1.5 cm x 15 cm column) and eluted using a linear NaCl gradient (100-300 mM NaCl over 5 column volumes). Proteins eluted and were collected at approximately 250 mM NaCl.
All protein manipulations were performed under anaerobic conditions maintained using either a Schlenk apparatus (9) or an anaerobic glovebox.
C12E8 crystals were obtained using microbatch 96 Well IMP@CTTM 376 Plates (Greiner Bio-One, Frickenhausen, Germany). The dimeric C12E8 PSIIcc at 2 mM Chl. solubilized in buffer containing 0.02 M MES/NaOH, pH 6.0, 0.01 M CaCl2, 0.5 M Betaine and 0.013 % C12E8 (MCB) buffer was mixed in 1:1 ratio with the crystallization solution which contained 0.1 M TRIS/HCl pH 7.5, 0.1 M (NH4)2SO4 (TN buffer) 14-18 % (w/v) polyethylene glycol 5000  monomethyl (PEG 5000 MME). Crystals grew at 20 °C and appeared after 2-3 day having a 382 size between 50-250 μm.
Wild-type ICH, the G150A, and the G150T mutants were crystallized by hanging drop vapor equilibration by mixing 2 μL of protein at 20 mg/ml and 2 μl of reservoir (23% PEG 3350, 100mM Tris-HCl, pH 8.6, 200 mM magnesium chloride and 2 mM dithiotheritol (DTT)) and incubating at 22°C. Spontaneous crystals in space group P21 appear in 24-48 hours and were used to microseed other drops
1 μL of 200 mM sodium dithionite solution was added to every well to ensure complete removal of any dissolved oxygen. For each drop, 200 nL of well solution and 200 nL of 100 μM dimeric BchL (in 100 mM HEPES pH 7.5, 150 mM NaCl, 10% (v/v) glycerol) were mixed. A crystal was observed after approximately one month with the well
solution consisting of 0.6 M sodium chloride, 0.1 M MES:NaOH pH 6.5, 20% (w/v) PEG 4000. Larger volume (3-4 μL) drops of the same well solution and protein concentration in 1:1, 1:2 and 2:1 ratios of protein to well solution yielded large single crystals after ~2-3 months. Prior to freez-ing, the well solution was mixed in an equal volume of cryoprotectant solution with a final con-centration of 9% sucrose (w/v), 2% glucose (w/v), 8% glycerol (v/v), and 8% ethylene glycol (v/v).
Av1-Se2B and all Av1-Se freeze-quenched samples were crystallized based on the sitting drop vapor diffusion method at 21°C in an anaerobic chamber containing a 95% Ar / 5% H2 atmosphere. The reservoir solution contained 24–28% PEG 8000 (v/v), 0.75–0.85 M NaCl, 0.1 M imidazole/malate (pH 7.5), 1% glycerol (v/v), 0.5% 2,2,2-trifluoroethanol (v/v) and 2.5 mM Na2S2O4. Additionally, a seeding strategy was applied to accelerate the crystallization process
Cryo-protection was achieved by transferring crystals into a 5 uL drop of reservoir solution containing 8–12% MPD (v/v).
Crystals were obtained by the anaerobic capillary batch method with 20% polyethylene glycol 8000 and 0.1 M CHES (pH 9.5) as precipitate
Crystals were grown by the capillary microbatch method (Georgiadis et al., 1992) with 30 ml of precipitant solution containing 25 to 30% PEG 4000, 140 to 200 mM Na2MoO4, 50 mM Tris-Cl (pH 8.0), and 15 ml of protein solution containing Av2 in 20% glycerol, 450 mM NaCl, 2 mM Na2S2O4 and 50 mM Tris-HCl (pH 8.0) in 1.5 mm melting point capillaries. The crystals reached a maximum size of 0.2 mm x 0.2 mm x 0.5 mm
The final protein was stored in Tris–HCl buffer, pH 8.0, with 250 mM NaCl, 2 mM dithionite
For crystallization, the protein was diluted to 38 mg/mL in 50 mM Tris buffer, pH 8.0, and 250 mM NaCl before setting up trials under anaerobic conditions in a nitrogen atmosphere glove box (UniLAB, MBRAUN, NH) using a micro-capillary batch diffusion method. The a-70Ile variant of the MoFe protein crystallized in 30% polyethylene glycol (PEG) 4000, 100 mM Tris (pH 8.0), 170–190 mM sodium molybdate and 1 mM dithionite
Av1* and Av1*(TOD) were crystallized by the sitting-drop vapor-diffusion method at 293 K in an anaerobic chamber containing a 95% N2/5% H2 atmosphere. The reservoir solution contained 17% (w/v) PEG Smear High, 0.16 M ammonium acetate, 0.1 M sodium citrate (pH 5.0), 25% (v/v) glycerol, and 5 mM Eu(II)-EGTA (for Av1*) or 5 mM dithionite (for Av1*(TOD)). The reservoir solution was degassed and saturated with N2. The first crystals were obtained 5 h after setting up the crystallization experiment. Crystals of sufficient size for the diffraction experiment were harvested after 12 h
The Fe protein was crystallized by microcapillary batch diffusion (8) using 30% PEG 4000, 0.1 M Tris-HCl (pH 8.5), 0.2 M sodium acetate, and 18% glycerol as precipitating solutions. The Fe protein crystals are brown in color and grow in 7 days to an average size of 0.3 mm x 0.4 mm x 0.6 mm. Prior to crystallization, MgADP was added to the protein to a final concentration of 10 mM
The MoFe-protein was crystallized by microcapillary batch diffusion using 30% PEG 8000, 0.2 M NaMoO4, and 0.1 M Tris (pH 8.5) as precipitating solution. The MoFe-protein crystals are dark brown in color and grow in 1-1.5 months to an average size of 0.1 x 0.3 x 0.8 mm
MoFe protein crystals were grown by the capillary batch diffusion method [17] in a solution containing 30% (w/v) polyethylene glycol (PEG) 4000, 0.1 M Tris (pH 8.0), 0.17 M Na2MoO4, and 0.001 M sodium dithionite. Prior to crystallization, both the protein solution and the precipitant solution were saturated with acetylene gas by sparging for 5 min. Crystals of dark brown colour with dimensions of ~200 μm x 200 μm x 200 μm were observed within 4–6 weeks. Crystals were treated with acetylene-saturated mother liquor supplemented with 15% (v/v) glycerol
Av1-CO was crystallized by the sitting-drop vapor diffusion method at ambient temperature under the strict exclusion of dioxygen in an inert gas chamber containing a 97/3% mixture of N2/H2 with < 1 ppm of O2 using a previously reported protocol.2 The looped crystals were carefully transferred to a homemade gas pressurization device4 and pressurized at 80 psi of CO for 2 min resulting in Av1(CO)2, after which they were quickly transferred to liquid nitrogen
βK400E-MoFeP crystals were grown using the sitting drop method. A 2 μL solution of 215 μM (50 mg/mL) βK400E-MoFeP in a buffered solution of 50 mM Tris, pH 8, 200 mM NaCl was mixed with 2 μL of well solution in the drops. Crystals were grown against a 0.25 mL well solution (18% polyethylene glycol (PEG) 10 000, 600 mM NaCl, 100 mM Tris, pH 8.0, and 5 mM Na2S2O4). Crystals were cryo-protected by soaking them in well solution containing 20% PEG 400
Three crystal forms of MoFe-protein, purified by protocols modified from (14) and (7) for the MoFe-proteins from A. vinelandii and Clostridium pasteurianum, respectively, were used in the structure determination. The A. vinelandii MoFe-protein (designated Avi) was crystallized by the microcapillary batch method (15) from 18% polyethylene glycol (PEG) 4000, 0.14 M NaCI, 0.10 M Na2MoO4, 80 mM tris-CI, pH 8.0, and -8 mg/ml protein. Two crystal forms of the C. pasteurianum MoFe-protein (designated Cpl) were obtained by crystallization from 15% PEG 4000, 0.21 M MgCl2, 80 mM tris HCl, pH 8.0, and -8 mg/ml protein (crystal form designated Mgl) and by crystallization from 18% PEG 4000, 0.3 M CsCl, and 80 mM tris HCl, pH 8.0, and -8 mg/ml protein (designated Csl)
Fe-protein and MoFe-protein from Azotobacter vinelandii were isolated and purified under anaerobic conditions as described previously. Crystals of the pcp/adp-complex were prepared under conditions similar to the pcp-complex in sitting drops by vapor diffusion in an anaerobic chamber at room temperature, using solutions and chemicals that were thoroughly deaerated using vacuum/Ar-fill cycles. Precipitating solutions contained 18-22% PEG 8000 (w/v), in addition to 0-50 mM NaCl, 100 mM Tris buffer (pH 8.5), and 10 mM sodium dithionite. The protein solutions were prepared by mixing appropriate amounts of Fe-protein and MoFe-protein stock solutions ([Fe-protein]stock= ~40 mg/ml, [MoFe-protein]stock= ~20 mg/ml), which were in 100 mM Tris (pH 7.75), 200 mM NaCl and 5 mM dithionite. Complex cocrystals were obtained using 1:1.2 to 1:1.5 MoFe-protein:Fe-protein ratios (v/v), corresponding to ~4 to 6-fold molar excess of Fe-protein per active site of MoFe-protein. The protein solutions also contained 10 mM MgCl2, 5 mM AMPPCP and 5 mM ADP, whose stock solutions (100 mM) were prepared in 100 mM Tris buffer (pH 8.5) immediately prior to setting up the crystallization trays. The crystallization drops contained 2 μl of the precipitating solution and 2 μl of the protein mixture, and the reservoir contained 250-500 μl of the precipitating solution
The protein was concentrated to 70 mg/mL prior to crystallization
Crystals were grown under anaerobic conditions in a Coy anaerobic chamber using the microcapillary batch diffusion method (20) with 24% poly(ethylene glycol), MW = 4000, as the precipitating agent in 0.16 M MgCl2, trishydrochloric acid, pH 8.5, 20% glycerol, and 1 mM sodium dithionite. The crystals are brown in color and grow to the approximate dimensions of 0.2 x 0.5 x 1 mm in ~2-3 weeks.
MoFe protein that was concentrated to ∼30 mg/mL and stored in the purification buffer. All trials were conducted under anaerobic conditions in a nitrogen atmosphere glovebox (UniLAB, M. Braun) using a microcapillary batch diffusion method. Crystallization was accomplished as previously described using a precipitating solution that contained 30% polyethylene glycol (PEG) 4000, 100 mM Tris-HCl (pH 8.0), 190 mM sodium molybdate, and 1 mM sodium dithionite. Crystals of a dark brown color with the approximate dimensions of 100 μm Å~ 200 μm Å~ 200 μm were observed after they had grown for 4−6 weeks. The crystals were cryoprotected by diffusion of mother liquor doped with ∼15% glycerol
Protein crystals were grown by capillary batch diffusion in a 100% N2 atmosphere MBRAUN glove box with precipitant solutions reported previously
The purified protein was dialyzed overnight against 10 mM NaCl in 25 mM Tris-HCl, pH 7.4, concentrated to 10.1 mg/ml
Crystallizations were set up under anaerobic conditions using the capillary liquid-liquid diffusion technique, essentially as for the wildtype protein. However, a lower final protein concentration of 1.3 mg/ml and a pH value of 7.4 was used in this case
Av1-CO and Av1-reactivated were crystallized by the sitting drop vapor diffusion method at 294 K in an anaerobic chamber containing a 95% Ar / 5% H2 atmosphere. The reservoir solution contained 21% PEG 4000 (v/v), 0.75 M NaCl, 0.1 M imidazole/malate (pH 7.5), 2 mM spermine, 1% glycerol (v/v), 0.5 % 2,2,2-trifluoroethanol (v/v) and 2.5 mM Na2S2O4. For Av1-CO, all crystallization solutions were saturated with CO and 300 μL (0.12 atm) CO were added to the headspace of each crystallization well before re-sealing the crystallization tray. Additionally a seeding strategy was applied to significantly accelerate the crystallization process and improve overall crystal shape. As a result, first crystals were obtained 2 h after setting up the crystallization experiment. Crystals of sufficient size for the diffraction experiment were harvested after 5 h. Cryo-protection was achieved by transferring crystals into the reservoir solution containing 5 % MPD (v/v) and 5 % 2,2,2-trifluoroethanol (v/v) pre- flushed with CO
MoFe protein was crystallized by sitting drop vapor diffusion at 291 K, in an anaerobic chamber at less than 5 ppm O2. 4 μL protein solution at 80 mg·mL–1 were mixed with the same volume of reservoir solution containing 0.55 M NaCl, 16.5% (v/v) PEG 6000, 12.5% (v/v) MPD, 1.5% (v/v) Xylitol, 0.2M imidazole/malate buffer at pH 8.0, 0.55 mM spermine, and 0.1 mM Zwittergent 3-14 (Hampton Research). Seeding was used to optimize the crystal shape. Crystals were transferred to harvesting buffers with stepwise increase of MPD concentrations up to 19% (v/v)
All Av1-Se samples were crystallized using the sitting drop vapor diffusion method at 21° C in an anaerobic chamber (5% H2 / 95% Ar), with protein concentration at 30 mg/mL. The reservoir solution consisted of
24-28% PEG 6000 (v/v), 750-850 mM NaCl, 100 mM imidazole/malic acid (pH 8.0), and 5 mM Na2S2O4. A seeding strategy using crushed Av1 crystals was employed to accelerate crystallization and to generate higher quality crystals. Cryo-protection of the crystals before freezing in liquid nitrogen consisted of dipping the crystals into a 5 uL drop of reservoir solution containing 8-12% MPD (v/v)
Crystals of nf-, pcp- and adp-Av2:Av1 complexes were prepared in sitting drops by vapor diffusion in an anaerobic chamber at room temperature. All solutions and chemicals used for crystallization were thoroughly deaerated using vacuum/Ar-fill cycles. Precipitating solutions for the nf-complex contained 16-18% (w/v) PEG 10000, and those for pcp- and adp- complexes contained 18-22% PEG 8000 (w/v), in addition to 0-50 mM NaCl, 100 mM Tris buffer (pH 8.5), and 10 mM dithionite. The protein solutions were prepared by mixing appropriate amounts of Av1 and Av2 stock solutions ([Av1]stock= ~20 mg/ml, [Av2]stock= ~40 mg/ml), both of which were in 100 mM Tris (pH 7.75), 200 mM NaCl and 5 mM dithionite. Best crystals for nf-, pcp- and adp-complexes were obtained using 1:1.2 to 1:1.5 Av1:Av2 ratios (v/v), corresponding to 5 to 6-fold molar excess of Av2 over per active site of Av1. The protein solutions for pcp- and adp-complexes also contained 10 mM MgCl2 (added from a 1 M stock), and 10 mM AMPPCP or ADP, whose 100 mM stock solutions were prepared in 100 mM Tris buffer (pH 8.5) immediately prior to setting up the crystallization trays. The crystallization drops contained 2 ml of the precipitating solution and 2 ml of the protein mixture, and the reservoir contained 250 ml of the precipitating solution
Protein stocks consisted of 30−35 mg/mL protein in a solution of 200 mM sodium chloride, 50 mM Tris/HCl at pH 7.75, and 5 mM sodium dithionite. Protein crystals were grown in 24-well plates using the sitting-drop method with a 1:1 ratio of protein stock to reservoir solution at room temperature in an anaerobic chamber with an atmosphere of ∼95% argon and ∼5% hydrogen. All solutions were made anaerobic through a series of vacuum and argon cycles. The reservoir solution for Av1 crystals consisted of double-distilled water, 15% polyethylene glycol (MW 4000 g/mol, Hampton Research), 0.5−0.8 M sodium chloride (VWR), 0.2 M imidazole/malate at pH 8 (Sigma-Aldrich), and 5 mM sodium dithionite (J.T. Baker). The reservoir solution for Cp1 crystals consisted of double-distilled water, 13.5−14% polyethylene glycol (MW 3350 g/mol, Hampton Research), 0.3−0.5 M magnesium chloride (Mallinckrodt), 0.08 M Tris/HCl at pH 8 (Fisher Scientific), and 5 mM sodium dithionite.
Cp1 was crystallized using sitting-drop vapor diffusion with a reservoir solution consisting of 0.2 M lithium citrate, 20%(w/v) polyethylene glycol (PEG) 3350 at room temperature (295 K) in a Coy anaerobic chamber.
The crystals were soaked in precipitation solution containing 10% 2-methyl-2,4-pentanediol (MPD) and 5 mM sodium dithionite for 15 min before flash-cooling.
Av1 was crystallized at 22 °C in an anaerobic chamber using the sitting drop method with mixed drops containing 2 μL of a 42 mg/mL Av1 solution and 4 μL of the precipitant. The precipitant contained 150 mM ACES, 75 mM Tris, 75 mM ethanolamine (pH 9.79), 17−18% PEG 3350, 0.8 M NaCl, and 1 mM sodium dithionite. Upon addition of the protein, the final pH of the mixed drop was 9.5. For cryoprotection, crystals of native Av1 grown at pH 9.5 were successively transferred into the reservoir solution with increasing concentrations of 2-methyl-2,4-pentanediol (MPD) up to 20%.
Purified BchL was diluted to a final concentration of 30 mg/mL in 50 mM Tris buffer (pH 7.8) with 350 mM NaCl and 2 mM dithionite prior to crystallization
Crystals were grown under anaerobic conditions in a nitrogen atmosphere glovebox (UniLAB, MBRAUN, NH) using a microcapillary batch diffusion method (9) with 20-25% PEG 3350 as the precipitating agent, with 200 mM magnesium formate (pH 7.7). A final concentration of 10 mM MgADP was added to the protein prior to crystallization. BchL cocrystallized with MgADP, with crystals appearing in 3-4 weeks as brown-colored long rods with dimensions of ∼600 μm x 50 μm x 50 μm.
Three crystal forms of MoFe-protein, purified by protocols modified from (14) and (7) for the MoFe-proteins from A. vinelandii and Clostridium pasteurianum, respectively, were used in the structure determination. The A. vinelandii MoFe-protein (designated Avi) was crystallized by the microcapillary batch method (15) from 18% polyethylene glycol (PEG) 4000, 0.14 M NaCI, 0.10 M Na2MoO4, 80 mM tris-HCI, pH 8.0, and -8 mg/ml protein. Two crystal forms of the C. pasteurianum MoFe-protein (designated Cpl) were obtained by crystallization from 15% PEG 4000, 0.21 M MgCl2, 80 mM tris HCl, pH 8.0, and -8 mg/ml protein (crystal form designated Mgl) and by crystallization from 18% PEG 4000, 0.3 M CsCl, and 80 mM tris HCl, pH 8.0, and -8 mg/ml protein (designated Csl)
Crystals of NifEN were cryogenically protected by stepwise transfer from mother liquor to a 10 μL drop of mother liquor in which 1-2 μg of sucrose were dissolved. Subsequently, they were transferred to an artificial mother liquor containing 25% (w/v) sucrose and flash frozen in liquid nitrogen.
All protein and crystal manipulations up to this step were performed in an inert gas atmosphere of 90% Ar and 10% H2.
Kp1 crystallizations were set up under an atmosphere of nitrogen (<3 ppm oxygen) in the glovebox and left undisturbed in a home-made water-jacketted cabinet within the glovebox. The latter was plumbed into an external thermostatted waterbath, which kept the temperature inside the crystallization cabinet at approximately 17 C. Crystals were grown using the liquid-liquid diffusion technique, with a 3:1 precipitant to protein ratio in 1 mm diameter siliconized glass capillaries (Alpha Laboratories), which were sealed at one end in a Bunsen burner flame. Crystallization conditions were based on those described (Roe et al., 1997). The precipitant was added first and consisted of 7% (w/v) polyethylene glycol (PEG) 6000, 0.4-0.6 M MgCl2, 50mM Tris-HCl (pH 8). The protein was carefully layered on top to give a final concentration of 3.3 mg/ml after equilibration.
Crystals were obtained by equilibrating a reservoir solution containing 13% polyethylene glycol 8000, 1 M sodium chloride and 0.1 M Tris-hydroxyethyl- aminomethane/HCl buffer at pH 8.0 against 8 μl of a 1:1 mixture of 30 mg/ml of MoFe protein and the reservoir solution under strictly anaerobic conditions. For flash-cooling, the crystals were successively transferred into harvesting solutions consisting of the reservoir solution and increasing amounts of 2-methyl-2,4-pentanediol (MPD). This was carried out in steps of 5 % MPD for 15 min each, until 20 % MPD were reached. Crystals were reduced by addition of 10 mM sodium dithionite to the cryo buffers
Crystals of the nitrogenase complex were obtained by the anaerobic capillary batch method with 16-20% PEG 8000, 0.1 M cacodylate, pH 6.5, and 20-50 mM MgCl2 as precipitate